Insider Transactions in Q4 2021 at Sab Biotherapeutics, Inc. (SABS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 26
2021
|
Russell P Beyer Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
278
-100.0%
|
$1,946
$7.9 P/Share
|
|
Oct 25
2021
|
Russell P Beyer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
129
+31.7%
|
$903
$7.78 P/Share
|
|
Oct 22
2021
|
David Charles Link |
BUY
Grant, award, or other acquisition
|
Indirect |
12,097
+50.0%
|
-
|
|
Oct 22
2021
|
David Charles Link |
BUY
Grant, award, or other acquisition
|
Direct |
15,820
+50.0%
|
-
|
|
Oct 22
2021
|
Frederick Finnegan Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,596
+50.0%
|
-
|
|
Oct 22
2021
|
Thomas Charles Luke Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,428
+50.0%
|
-
|
|
Oct 22
2021
|
Eddie Joe Sullivan PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
5,213,764
+50.0%
|
-
|
|
Oct 22
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
4,974,497
+50.0%
|
-
|
|
Oct 22
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
5,049,351
+50.0%
|
-
|
|
Oct 22
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
5,049,351
+50.0%
|
-
|
|
Oct 22
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
4,974,497
+50.0%
|
-
|
|
Oct 19
2021
|
Thomas Charles Luke Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
990
+50.0%
|
$9,900
$10.1 P/Share
|
|
Oct 18
2021
|
Russell P Beyer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,475
+50.0%
|
$24,750
$10.1 P/Share
|
|
Oct 14
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
5,092
+50.0%
|
$50,920
$10.1 P/Share
|
|
Oct 14
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
5,092
+50.0%
|
$50,920
$10.1 P/Share
|
|
Oct 14
2021
|
Samuel J Reich CEO & EXECUTIVE CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$10,000
$10.11 P/Share
|
|
Oct 13
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
20,800
+50.0%
|
$208,000
$10.1 P/Share
|
|
Oct 13
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
20,800
+50.0%
|
$208,000
$10.1 P/Share
|
|
Oct 13
2021
|
Ilan Katz Director |
BUY
Open market or private purchase
|
Direct |
500
+25.0%
|
$5,000
$10.11 P/Share
|
|
Oct 12
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
25,000
+50.0%
|
$250,000
$10.08 P/Share
|
|
Oct 12
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
$250,000
$10.09 P/Share
|
|
Oct 12
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
50,000
+50.0%
|
$500,000
$10.09 P/Share
|
|
Oct 07
2021
|
Eddie Joe Sullivan PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+50.0%
|
$28,000
$10.07 P/Share
|
|
Oct 01
2021
|
Christine E Hamilton |
BUY
Grant, award, or other acquisition
|
Indirect |
2,695
+50.0%
|
$26,950
$10.1 P/Share
|
|
Oct 01
2021
|
Edward D. Hamilton > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
2,695
+50.0%
|
$26,950
$10.1 P/Share
|
|
Oct 01
2021
|
Ilan Katz Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$10,000
$10.09 P/Share
|
|
Oct 01
2021
|
Jeffrey G Spragens |
BUY
Open market or private purchase
|
Direct |
13,000
+50.0%
|
$130,000
$10.07 P/Share
|